Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

12 Aug 2008

Abstract excerpt

PURPOSE: Recently, several prognostic gene expression signatures have been identified; however, their performance has never been evaluated according to the previously described molecular subtypes based on the estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2), and their biological meaning has remained unclear. Here we aimed to perform a comprehensive meta-analysis integrating both...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Cancer Treatment Studies
Share to Cancer Immunotherapy and Biomarkers
Share to HER2/EGFR in Cancer Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 18698033
DOI: 10.1158/1078-0432.ccr-07-4756

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular SubtypesPMID 18698033Read ↗

Gene Pathways Associated With Prognosis and Chemotherapy Sensitivity in Molecular Subtypes of Breast CancerSemantic proximity Read ↗

Gene Modules and Response to Neoadjuvant Chemotherapy in Breast Cancer Subtypes: A Pooled AnalysisSemantic proximity Read ↗

Development of a Prognostic Model for HR-positive HER2-negative and Node-negative Breast Cancer: Integrating Clinical and Transcriptional BiomarkersSemantic proximity Read ↗

Tumor microenvironment subtypes and immune-related signatures for the prognosis of breast cancerSemantic proximity Read ↗

Immune Infiltration Correlates with Transcriptomic Subtypes in Primary ER+ Invasive Lobular Breast CancerSemantic proximity Read ↗

Integrated immune-related gene signature predicts clinical outcome for patients with Luminal B breast cancerSemantic proximity Read ↗

A novel immune subtype classification of ER-positive, PR-negative and HER2-negative breast cancer based on the genomic and transcriptomic landscapeSemantic proximity Read ↗

Tumor Cell Intrinsic And Extrinsic Features Predicts Prognosis In Estrogen Receptor Positive Breast CancerSemantic proximity Read ↗

An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancerSemantic proximity Read ↗

Novel Immune Subtypes Identification of HER2 Positive Breast Cancer Based On Immunogenomic LandscapeSemantic proximity Read ↗

Identification of A 10-Gene Signature To Predict Efficacy of Neoadjuvant Therapy in Patients With HER2 Positive Breast Cancer.Semantic proximity Read ↗

Identification of immune-related biomarkers for predicting neoadjuvant chemotherapy sensitivity in HER2 negative breast cancer via bioinformatics analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.